India's Comprehensive Economic Partnership Agreement with Oman comes into effect on June 1, granting New Delhi 100% duty-free access for 98...

India has eased Foreign Direct Investment rules for companies with up to ten percent Chinese or Hong Kong shareholding. These firms can now...

India and New Zealand signed a “once-in-a-generation” free trade agreement on Monday that gives New Delhi duty-free access to 100% of tarif...

Saurabh Mukherjea believes India's long-standing economic model is concluding. He anticipates rising inflation and a weakening rupee impact...

FDI policy provides for 100 per cent FDI under automatic route in greenfield pharma and upto 100 per cent under government route in brownfi...

"The pharma industry is growing by 14 per cent every year. With relaxed FDI norms, I think pharma sector will grow by 20 per cent," Kumar s...

The committee demands caution on the issue from the government and reiterates its recommendation to impose a blanket ban in FDI in brown fi...

The government had cleared a Rs 5,168 crore proposal of US-based pharma firm Mylan Inc's to acquire Indian generic drugs company Agila Spec...

FIPB will take up tomorrow GlaxoSmithKline's Rs 6,400 crore FDI plan, the largest foreign investment proposal in the pharma sector this fis...

FDI in drugs and pharmaceuticals was at $580 million during April-October 2012, according to the data of the Department of Industrial Polic...

It is welcome that the Cabinet has shot down a proposal to restrict foreign direct investment (FDI) in the pharmaceutical sector.

Currently, 100 per cent FDI is permitted in brownfield pharma firms through clearance from the Foreign Investment Promotion Board (FIPB).

The Ministry of Commerce and Industry has proposed tighter overseas investment norms in existing drug companies by limiting all forms of fo...

Faced with rush of multinationals to acquire Indian pharma firms, the Commerce and Industry Ministry is proposing to tighten the FDI policy...

The Cabinet will take up the issue of relaxing FDI norms in about a dozen sectors next week, Commerce and Industry Minister Anand Sharma sa...

The DIPP said current norms must lay down the foundation of what should be the nature of Indian drug companies in the long term.

The government is likely to finalise FDI policy with regard to existing drug companies ahead of the FIPB meeting on July 5.